These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8972123)

  • 1. Immunotherapy with Mycobacterium vaccae and the treatment of tuberculosis.
    Stanford JL; Stanford CA
    Soc Appl Bacteriol Symp Ser; 1996; 25():81S-86S. PubMed ID: 8972123
    [No Abstract]   [Full Text] [Related]  

  • 2. Modern short-course regimens in the treatment of tuberculosis.
    Fox W
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):122-32. PubMed ID: 2999948
    [No Abstract]   [Full Text] [Related]  

  • 3. Does immunotherapy with heat-killed Mycobacterium vaccae offer hope for the treatment of multi-drug-resistant pulmonary tuberculosis?
    Stanford JL; Stanford CA; Grange JM; Lan NN; Etemadi A
    Respir Med; 2001 Jun; 95(6):444-7. PubMed ID: 11421500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected ugandan adults with newly diagnosed pulmonary tuberculosis. The Uganda-Case Western Reserve University Research Collaboration.
    Johnson JL; Kamya RM; Okwera A; Loughlin AM; Nyole S; Hom DL; Wallis RS; Hirsch CS; Wolski K; Foulds J; Mugerwa RD; Ellner JJ
    J Infect Dis; 2000 Apr; 181(4):1304-12. PubMed ID: 10753731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical value of determining Mycobacterium tuberculosis in sputum and bronchial washings].
    Rudoĭ NM; Eliseev VV; Asambaev AA; Temirgalieva RU
    Lab Delo; 1970; 10():614-8. PubMed ID: 4099567
    [No Abstract]   [Full Text] [Related]  

  • 6. [A clinical study on vaccine of Mycobacterium vaccae in treating pulmonary tuberculosis].
    Wang W; Jin G; Ye Y; Xia X; Wang A; Zhuang Y; Li G; Sun H; Wang Z; Lin M; Chen H; Li J; Dan Z; Zhang X
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Feb; 22(2):108-10. PubMed ID: 11820954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of Mycobacterium tuberculosis polydrug resistance in chronic destructive forms of pulmonary tuberculosis].
    Bialik IB; Klimenko MT
    Probl Tuberk; 1980 Oct; (10):68-70. PubMed ID: 6776517
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological basis for the introduction of immunotherapy with Mycobacterium vaccae into the routine treatment of TB.
    Dlugovitzky D; Stanford C; Stanford J
    Immunotherapy; 2011 Apr; 3(4):557-68. PubMed ID: 21463195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trial. Durban Immunotherapy Trial Group.
    Lancet; 1999 Jul; 354(9173):116-9. PubMed ID: 10408487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interrelation between the isolation of Mycobacterium tuberculosis and Candida from patients with pulmonary tuberculosis].
    Levina EL
    Probl Tuberk; 1969; 47(9):78-82. PubMed ID: 4989794
    [No Abstract]   [Full Text] [Related]  

  • 11. [The immunotherapeutic effect of Mycobacterium vaccae vaccine on initially treated pulmonary tuberculosis].
    Luo Y;
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jan; 24(1):43-7. PubMed ID: 11802939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Mycobacterium vaccae immunotherapy for patients with tuberculosis: A systematic review and meta-analysis.
    Huang CY; Hsieh WY
    Hum Vaccin Immunother; 2017 Sep; 13(9):1960-1971. PubMed ID: 28604170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium vaccae immunotherapy for treating tuberculosis.
    de B; Garner P
    Cochrane Database Syst Rev; 2001; (1):CD001166. PubMed ID: 11279709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Problems in the treatment of patients with pulmonary tuberculosis].
    Chukanov VI
    Probl Tuberk; 1997; (4):17-9. PubMed ID: 9333807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Spread of drug-resistant strains of mycobacterium tuberculosis among patients with isolated bacteria].
    Zhukova MP
    Probl Tuberk; 1998; (1):14-6. PubMed ID: 9553424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterium vaccae immunotherapy for treating tuberculosis.
    de Bruyn G; Garner P
    Cochrane Database Syst Rev; 2003; (1):CD001166. PubMed ID: 12535403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
    Trébucq A; Rieder HL
    Int J Tuberc Lung Dis; 1998 Mar; 2(3):184-6. PubMed ID: 9526189
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis.
    Stanford J; Stanford C; Grange J
    Front Biosci; 2004 May; 9():1701-19. PubMed ID: 14977580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appropriateness of extending the intensive phase of treatment based on smear results.
    Enarson DA; Jindani A; Kuaban C; Lamothe F; Louissaint M; Ottmani SE; Ramarokoto H; Ridderhof JC; Urbanczik R
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):114-6. PubMed ID: 14974754
    [No Abstract]   [Full Text] [Related]  

  • 20. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
    Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
    Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.